CVS Health to split, separate pharmacy business from insurance
Key Points:
- CVS Health announced plans to split into two separate companies, separating its retail pharmacy business from its insurance and pharmacy-benefit management operations, with the separation expected to be completed by the first half of 2028.
- The decision comes amid increasing regulatory scrutiny of vertically integrated healthcare companies, which critics argue can create conflicts of interest, limit competition, and drive up healthcare costs.
- CVS built its current conglomerate through acquisitions, including the $78 billion purchase of Aetna in 2018, but the split marks a strategic reversal aimed at improving consumer engagement, affordability, and care coordination.
- The company’s shares fell over 10% in early trading following the announcement, with analysts attributing the decline to deal uncertainty and broader healthcare sector volatility, though some view the split positively due to recent improvements in CVS Pharmacy’s financial performance.
- CVS also reported strong third-quarter earnings, beating profit estimates and raising its annual profit forecast, but maintained a cautious outlook due to ongoing elevated medical costs and potential economic challenges.